ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
8.17
-0.08 (-0.97%)
At close: Mar 20, 2026, 4:00 PM EDT
8.31
+0.14 (1.71%)
After-hours: Mar 20, 2026, 7:07 PM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $811.26 million as of March 20, 2026. Its market cap has decreased by -22.64% in one year.
Market Cap
811.26M
Enterprise Value
734.79M
1-Year Change
-22.64%
Ranking
Category
Stock Price
$8.17
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $811.26M, an increase of 42.77%. That is a compound annual growth rate of 11.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 811.26M | -29.55% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UroGen Pharma | 857.78M |
| Janux Therapeutics | 855.29M |
| SELLAS Life Sciences Group | 854.81M |
| Evommune | 840.31M |
| Sana Biotechnology | 829.96M |
| Adlai Nortye | 819.19M |
| Arbutus Biopharma | 815.45M |
| Inventiva | 804.29M |